Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S18 pseudogene 9 (RPS18P9) is a processed pseudogene present in the human genome, related to the ribosomal protein S18 gene family[5][2]. Pseudogenes are segments of DNA that are similar to known genes but are typically nonfunctional due to mutations or lack of regulatory elements required for gene expression. RPS18P9 does not encode a protein product and is not involved in any known cellular processes or disease mechanisms. It is not considered a therapeutic target, receptor, or biomarker in research or medicine[5][2].\n\nSummary: RPS18P9 is not a functional gene, not a therapeutic or research target, and not involved in drug action or disease biology[5][2]. Its only role is as a genomic segment with homology to the ribosomal protein S18 gene, likely arising from evolutionary duplication and subsequent loss of function (pseudogenization)[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S18 pseudogene 9 (RPS18P9).